
Franz-Josef Neumann
As one of Germany's senior cardiologists, Professor Franz-Josef Neumann played a pivotal role in the merger of two of the country's major cardiac centres to form the University Heart Center Freiburg, Bad Krozingen - Germany.
It is the latest phase of a career that has also included important research which linked reversible ischaemia and inflammation and also studies that established dual antiplatelet therapy for stent placement as the standard of care.
A member of the International Editorial Board of the European Heart Journal, he was born and brought up in Aachen, where his father was a technician at the Department of Physics of the University of Aachen, and educated at an ‘old-fashioned grammar school’ in the city where he enjoyed ‘getting in touch with the thoughts of the ancient Romans and Greeks’.
He studied medicine at the University of Aachen, spending his final year at Westminster Medical School in London where his academic teachers gave him the enthusiasm to pursue a career in cardiology.
In 1991, Professor Albert Schömig, Chair of Cardiology at the University of Munich, offered Professor Neumann the position of Senior Staff Physician and Head of the Catheterization Laboratory. He then became Associate Professor of Clinical and Interventional Cardiology at the Technical University of Munich in 1996.
Of the people who have shaped his career, he believes Professor Schömig was the biggest influence.
In October 2001, he became the Medical Director and Chairman of the Heart Center Bad Krozingen, which was already one of the biggest heart centres in Germany, and in 2012 merged his centre with the cardiovascular departments of the Medical Faculty of the University of Freiburg to form the University Heart Center Freiburg, Bad Krozingen.
Currently, Medical Director of the Division of Cardiology and Angiology II and serves as Deputy Medical Director of the University Heart Center Freiburg · Bad Krozingen, he is also Endowed Professor of Cardiovascular Medicine of the University of Freiburg.
Other research for Professor Neumann is around optimization of reperfusion in myocardial infarction as well fostering the research groups within his institution in the field of electrophysiology, heart failure and interventional angiology.
Latest contributions
DCB PCI for de novo lesions: when and how?
15 May 2024 – From EuroPCR 2024
In this session, you will learn how to optimally perform DCB PCI, identify which lesions are best suited for this approach, and understand when it's necessary to switch from DCB to stent PCI. The session also features a debate on whether DCB-PCI should be the first...

Has the 2023 ESC-EACTS guideline review on left main changed my practice?
15 May 2024 – From EuroPCR 2024
Watch this session if you wish to learn why the 2019 guidelines were revised, how to apply the updated recommendations in clinical settings through case examples, and the criteria for selecting patients with left main stenosis for PCI versus CABG.
The session includes detailed presentations on...

Complex PCI in multivessel disease
14 May 2024 – From EuroPCR 2024
This session features selected clinical case submissions focused on complex PCI (Percutaneous Coronary Intervention) in patients with multivessel disease. Participants will learn about various challenging cases, including navigating heart failure, three-vessel disease with functional mitral regurgitation, complete revascularization assisted by Impella, and end-stage refractory angina. The...

PCR's Got Talent - Round 1 - Session 1
16 May 2023 – From EuroPCR 2023
Have you attended this session and wish a memory boost? Look at the slides presented by the speakers and review what is important to remember.

Role of physiology during PCI
19 May 2022 – From EuroPCR 2022
Follow, LIVE from Barcelona, Spain, the case of a 61-year-old female patient, former smoker, diabetic, suffering from hypercholesterolemia, dyspnea, and chest pain on exertion for years, admitted for NYHA III heart failure, and discover the importance of physiology and intracoronary imaging in daily practice.

Complex heart problems in cancer patients
19 May 2022 – From EuroPCR 2022
TAVI and thrombocytopenia, TAVI, CAD and hepatocarcinoma, or even severe aortic regurgitation and ovarian cancer with infective endocarditis: analyze the case of different cancer patients to be treated for cardiac pathologies in this session from EuroPCR 2022.

Role of OCT in multivessel PCI
18 May 2022 – From EuroPCR 2022
How would you treat a 67-year-old male patient with dyslipidemia and family history of CAD, referred for coronary angiography because of severe, significant silent myocardial ischemia? Watch this LIVE case from Toulouse, France, to find out what your peers' choices are.

EuroPCR 2022 Hotlines / Late-Breaking Trials in TAVI: TRANSIT-PPM, LYTEN, SCOPE 2, and more!
18 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in TAVI! Balloon vs. self-expanding valves in valve-in-valve TAVI, trilogy for treatment of aortic regurgitation, management of Myocardial Revascularization in Patients with Stable Coronary Artery Disease Undergoing TAVI, SCOPE 2 subanalysis, prosthesis-patient mismatch following TAVR, and stroke complicating...

Antithrombotics in practice after PCI: from evidence to individual patient management
17 May 2022 – From EuroPCR 2022
In this session, compare the case of a typical ACS PCI patient with two cases with chronic settings to see whether there are other options to be considered as far as antithrombotic strategy is concerned.

Hot line on PCI: high bleeding risk and DAPT - part 1
26 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on high bleeding risk and DAPT presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: ARC-HBR, MODEL U-SES, Onyx ONE trials.

Trials and registries - Long term clinical outcomes after BRS implantation
23 May 2019 – From EuroPCR 2019
Consult this session to learn more about the latest trials and registries regarding the long term clinical outcomes after BRS implantation: GABI-R, ABSORB, PRAGUE-19, and more!

Acute heart failure: invasive treatment
23 May 2019 – From EuroPCR 2019
Consult this session on invasive treatment for acute heart failure and discover compelling clinical cases such as a triple ECMO therapy and dual PCI with stenting performed in a pediatric heart transplant patient, a catheter-directed thrombolysis in acute submassive pulmonary embolism, and more!

Prevention and management of iatrogenic coronary dissection - Part 1
23 May 2019 – From EuroPCR 2019
Consult this session to learn more about how to prevent and manage iatrogenic coronary dissection, with compelling clinical cases such as an iatrogenic dissection of trifurcated left main, an aorto-ostial dissection in heavily calcified right coronary artery, and more!

Trials and registries - Clinical outcomes after DES implantation for complex PCI
22 May 2019 – From EuroPCR 2019
Consult this session to learn all about the latest trials and registries regarding the clinical outcomes after DES implantation for complex PCI: rTAP, MECAST, Celtic Bifurcation, and more!
